A Multicentre Phase I Study Of Cremophor FreePaclitaxel Nanoparticle In Advanced Breast Cancer.

Trial Profile

A Multicentre Phase I Study Of Cremophor FreePaclitaxel Nanoparticle In Advanced Breast Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Fresenius Kabi
  • Most Recent Events

    • 15 Feb 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India
    • 03 Jul 2009 New source identified and integrated (Clinical Trials Registry - India record no. CTRI2009-091-000219).
    • 03 Jul 2009 Additional trial identifier UTRN115924240-290420096391230 and CTRI2009-091-000219 identified as reported by Clinical Trials Registry - India.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top